Literature DB >> 9640303

Prevalence of Wernicke-Korsakoff syndrome in Australia: has thiamine fortification made a difference?

C G Harper1, D L Sheedy, A I Lara, T M Garrick, J M Hilton, J Raisanen.   

Abstract

OBJECTIVE: To determine the prevalence of the Wernicke-Korsakoff syndrome (WKS) in Australia and compare this with previous studies. DESIGN AND
SETTING: Prospective autopsy study at the New South Wales Institute of Forensic Medicine, 1996-1997.
METHODS: Brains of deceased people (aged over 15 years) derived from 2212 sequential autopsies performed between 1 January 1996 and 31 December 1997 were studied macroscopically and microscopically to identify cases of WKS. MAIN OUTCOME MEASURES: Standard histological criteria for WKS and any available clinical data.
RESULTS: Twenty-five cases of WKS were identified (prevalence, 1.1%), mostly among the 5.9% of the 2212 people who had a history suggestive of alcohol abuse. Only four cases (16%) had been diagnosed during life.
CONCLUSIONS: There has been a significant reduction in the prevalence of WKS in Australia since the introduction of thiamine enrichment of bread flour. While the prevalence is still higher than in most other Western countries, further research is needed before adding thiamine to alcoholic beverages can be recommended.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9640303      PMCID: PMC3391549          DOI: 10.5694/j.1326-5377.1998.tb139081.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  13 in total

1.  Lack of avitaminosis among alcoholics: its relation to fortification of cereal products and the general nutritional status of the population.

Authors:  W G FIGUEROA; F SARGENT; L IMPERIALE; G R MOREY; C R PAYNTER; L J VORHAUS; R M KARK
Journal:  J Clin Nutr       Date:  1953 Mar-Apr

2.  Transneuronal mammillary atrophy.

Authors:  T Schubert; R L Friede
Journal:  J Neurol       Date:  1979-08       Impact factor: 4.849

3.  The prevalence of the Wernicke-Korsakoff syndrome in Sydney, Australia: a prospective necropsy study.

Authors:  C Harper; J Gold; M Rodriguez; M Perdices
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

4.  The supplementation of alcoholic beverages with thiamine--a necessary preventive measure in Queensland?

Authors:  J Price; M T Theodoros
Journal:  Aust N Z J Psychiatry       Date:  1979-12       Impact factor: 5.744

5.  Wernicke's encephalopathy: a more common disease than realised. A neuropathological study of 51 cases.

Authors:  C Harper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-03       Impact factor: 10.154

6.  Cerebral disorder in alcoholism: syndromes of impairment.

Authors:  W A Lishman
Journal:  Brain       Date:  1981-03       Impact factor: 13.501

7.  The incidence of Wernicke's encephalopathy in Australia--a neuropathological study of 131 cases.

Authors:  C Harper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-07       Impact factor: 10.154

8.  Clinical thiamine deficiency in Australia: the size of the problem and approaches to prevention.

Authors:  B Wood; K J Breen
Journal:  Med J Aust       Date:  1980-05-17       Impact factor: 7.738

Review 9.  Alcohol and the brain.

Authors:  W A Lishman
Journal:  Br J Psychiatry       Date:  1990-05       Impact factor: 9.319

10.  Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy.

Authors:  C G Harper; M Giles; R Finlay-Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

View more
  23 in total

1.  The Effect of Chronic Ethanol Exposure and Thiamine Deficiency on Myelin-related Genes in the Cortex and the Cerebellum.

Authors:  Bradley J Chatterton; Polliana T Nunes; Lisa M Savage
Journal:  Alcohol Clin Exp Res       Date:  2020-11-24       Impact factor: 3.455

Review 2.  Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: A review.

Authors:  Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychology       Date:  2019-09       Impact factor: 3.295

3.  Size of mamillary bodies in health and disease: useful measurements in neuroradiological diagnosis of Wernicke's encephalopathy.

Authors:  D Sheedy; A Lara; T Garrick; C Harper
Journal:  Alcohol Clin Exp Res       Date:  1999-10       Impact factor: 3.455

4.  Using clinical decision support through the electronic medical record to increase prescribing of high-dose parenteral thiamine in hospitalized patients with alcohol use disorder.

Authors:  Jonathan M Wai; Christopher Aloezos; Wenzhu B Mowrey; Sarah W Baron; Regina Cregin; Howard L Forman
Journal:  J Subst Abuse Treat       Date:  2019-01-23

5.  Signs of preclinical Wernicke's encephalopathy and thiamine levels as predictors of neuropsychological deficits in alcoholism without Korsakoff's syndrome.

Authors:  Anne-Lise Pitel; Natalie M Zahr; Karen Jackson; Stephanie A Sassoon; Margaret J Rosenbloom; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Neuropsychopharmacology       Date:  2010-10-20       Impact factor: 7.853

Review 6.  Neuroimaging findings in pediatric Wernicke encephalopathy: a review.

Authors:  Giulio Zuccoli; Nasir Siddiqui; Ariel Bailey; Stefano C Bartoletti
Journal:  Neuroradiology       Date:  2009-10-21       Impact factor: 2.804

7.  Non-alcoholic Wernicke encephalopathy: great masquerader.

Authors:  Chukwudumebi Okafor; Manojna Nimmagadda; Sarthak Soin; Lavanya Lanka
Journal:  BMJ Case Rep       Date:  2018-12-27

Review 8.  Human alcohol-related neuropathology.

Authors:  Suzanne M de la Monte; Jillian J Kril
Journal:  Acta Neuropathol       Date:  2013-12-27       Impact factor: 17.088

Review 9.  Wernicke's encephalopathy: expanding the diagnostic toolbox.

Authors:  Mary E Lough
Journal:  Neuropsychol Rev       Date:  2012-05-11       Impact factor: 7.444

Review 10.  The evolution and treatment of Korsakoff's syndrome: out of sight, out of mind?

Authors:  A D Thomson; Irene Guerrini; E Jane Marshall
Journal:  Neuropsychol Rev       Date:  2012-05-09       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.